Protecting against a "tripledemic": Vaccinating for the flu, RSV, and COVID-19
17 Aug 2023
Vaccine
WASHINGTON, Aug. 17, 2023 /PRNewswire/ -- With school sessions resuming and the fall vaccination season fast approaching, the American Pharmacists Association (APhA) is offering reporters and editors opportunities to interview practicing pharmacists about the latest guidance on vaccinations for COVID-19, respiratory syncytial virus (RSV), and seasonal influenza.
Pharmacists are available to discuss the following:
The most current recommendations for the COVID-19 vaccine and possible future recommendations
The most current recommendations for the RSV vaccine, such as who should get it and when
The most current recommendations for the 2023–2024 seasonal flu vaccine
These interviews can be conducted live or recorded for future publication and broadcast.
Why it matters
Weekly hospital admissions for COVID-19 are rising for the first time since last winter.
Pharmacists are among the leading providers of routine vaccinations across the country. Recent studies have found that pharmacists have administered the majority of COVID-19 vaccinations, with more than 305 million doses of the vaccine delivered by pharmacists through May 2023.
APhA also observes National Immunization Awareness Month, an annual CDC program that highlights the importance of routine vaccination for people of all ages.
About the American Pharmacists Association
The American Pharmacists Association is the only organization advancing the entire pharmacy profession. Our expert staff and strong volunteer leadership, including many experienced pharmacists, allow us to deliver vital leadership to help pharmacists, pharmaceutical scientists, student pharmacists, and pharmacy technicians find success and satisfaction in their work and advocate for changes that benefit them, their patients, and their communities. For more information, please visit pharmacist.com.
SOURCE American Pharmacists Association
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
-Targets
-Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.